• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec19
Teva's CFO Sells Company Shares
15:15
Alvotech and Teva Reach Settlement with Regeneron for AVT06 US Launch
08:32
Dec18
Teva Pharmaceuticals Director Roberto Minio Sells Common Stocks
21:03
Dec16
FactSet Upgrades Teva Pharmaceutical's Target Price Estimate
12:22
JPMorgan Raises Teva Pharmaceuticals Target Price to $35
05:27
Dec13
Wall Street Zen Downgrades Teva Pharmaceutical to Buy
07:11

Schedules & Filings

Schedules
Filings
Jan28
Earning Release(EST)

FY2025 Q4 Earning Release

Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 4.48 B, Net Income 433 M, EPS 0.37

Jul30
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 4.176 B, Net Income 282 M, EPS 0.24

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
LAZR
0.6044
+174.73%
+0.384
NBY
5.300
+79.66%
+2.350
MIMI
0.4795
+75.45%
+0.206
AZI
2.500
+64.47%
+0.980
GDC
5.260
+51.59%
+1.790
SOS
2.200
+47.65%
+0.710
IBO
0.6491
+46.26%
+0.205
FLYT
17.130
+45.42%
+5.350
CRWG
3.950
+45.22%
+1.230
CRWU
7.290
+44.93%
+2.260
View More